Skip to main content
Oct 8, 2024 — Oct 9, 2024
  • Seminar

Complimentary Open Consultation Discussions

Meet with our experts to discover how we can support you in navigating complex medical device regulatory landscapes.

A board meeting inside a glass conference room

Date & Time

Starts

Oct 8, 2024 2:00pm SGT

Ends

Oct 9, 2024 5:00pm SGT

Location

1 HarbourFront Place
#11-01 to 03, Harbourfront Tower 1 
Singapore 098633

Language

English

We are excited to announce the first installment of our complimentary Open Consultations, where you can address some of your regulatory questions with our expert consulting manager Sreenu Sattu and discover how we can support your medical device registration and compliance efforts in markets worldwide.

With 22 years of experience, we’re equipped to address your toughest challenges and provide tailored support for your regulatory needs.

We at Emergo by UL are aware of the complicated issues that the medical device sector must contend with because of regulatory restrictions, and we have built our services with these issues in mind.

For one or more products, we create specialized regulatory plans that can assist you in extending your global market reach.

Discover how we can support you in navigating complex medical device regulatory landscapes

Schedule a meeting

 

About our expert consulting manager

Sreenu Sattu

Sreenu Sattu, manager QA/RA

Sreenu Sattu has more than 17 years of healthcare industry experience, focusing on medical devices and in vitro diagnostic devices, and covering products of all risk classifications. Sattu’s background includes establishing regulatory strategies for registrations, integration activities, compiling EU technical files, CSDTs for APAC submissions, U.S. FDA 510ks, and TGA submissions, including Clinical Evaluation Reports and Post Market Surveillance. He also has experience in ISO 13485 audits, gap assessments and US FDA QSIT Inspections.

In his current role, Sreenu manages the regulatory and quality compliance needs of Emergo’s APAC and international clients. Prior to joining Emergo by UL, he held regional and leadership positions at Life Technologies (now part of Thermo Fisher Scientific), Vela Diagnostics, Cardinal Health and Abbott.

Any advice or information provided in the consulting session is not to be relied upon as professional, business, or legal advice. Emergo and its Affiliates expressly disclaim any and all liability for any damages which may arise in relation to a party's reliance upon any advice or consulting provided.